First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX

Completed · Phase 2/Phase 3

Conditions studied: Colorectal Cancer

In brief

The purpose of this study is to see if Cediranib in combination with FOLFOX is effective in treating metastatic colorectal cancer and to see how it compares with Avastin (Bevacizumab) in combination with FOLFOX.

Key facts

Study ID
NCT00384176
Run by
AstraZeneca
People needed
1814
Starts
2006-08-30
Expected to finish
2015-08-19
Last updated by the study team
2017-04-14

Who can join

Age: 18 and older, up to 130. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.